Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro

Archives of Physiology and Biochemistry

Volumn 107, Issue 4, 1999, Pages 286-291

  Durmaz, Ramazan ^a   Deliorman, S ^a   Isiksoy S ^a   Uyar, R ^a   Tel, E ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

LHRH; Meningioma; Primary cell culture

Indexed keywords

GONADORELIN;

ARTICLE; CELL PROLIFERATION; FEMALE; GONADORELIN RELEASE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MENINGIOMA; TUMOR GROWTH;

EID: 0033504207     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/1381-3455(199908)107:04;1-q;ft286     Document Type: Article

References (26)

1. Bickerstaff ER, Small JM, Guest IA (1958): The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21: 89-91.
2. Chen TT, Mealey J (1970): Microculture of human brain tumors. Cancer Chemother Rep 54: 9-14.
3. da Motta LA, da Motta LD (1995): Endocrine treatment of meningiomas: A review. Arq Neuropsiquiatr 53: 324-332.
4. Emons G, Schally AV (1994): The use of luteinizing hormone relasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 9: 1364-1379.
5. Freshney RI (1994): Culture of Animal Cells: A Manual of Basic Technique. New York: Wiley-Liss, pp. 197-218.
6. Goodwin JW, Crowley J, Eyre HJ, Stafford B, Jaeckle KA, Townsend JJ (1993): A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group study. J Neurooncol 15: 75-77.
7. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991): Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74: 861-866.
8. Hershkovitz E, Marbach M, Bosin E, Levy J, Roberts CT, LeRoith D, Schally AV, Sharoni Y (1993): Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors. J Clin Endocrinol Metab 77: 963-968.
9. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL (1986): Proliferative potential of human meningiomas of the brain: a cell kinetics study with bromodeoxyuridine. Cancer 58: 1466-1472.
10. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1995): Growth rate of intracranial meningioma: Tumor doubling time and proliferating cell nuclear antigen staining index. Neurol Med Chir (Tokyo) 35: 289-293.
11. Jay JR, Mclaughlin DT, Riley KR, Murtaza RL (1985): Modulation of cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757-762.
12. Kajikawa H, Kawamoto K, Herz F, Wolley RC, Hirano A, Koss LG (1978): Flow-through cytometry of meningiomas and cultured meningioma cells. Acta Neuropathol (Berl) 44: 183-187.
13. Michelsen JJ, New PFJ (1969): Brain tumor and pregnancy. J Neurol Neurosurg Psychiatry 32: 305-307.
14. Milovanovic SR, Monje E, Szepeshazi K, Radulovic S, Schally A (1993): Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing hormone-releasing hormone in MXT mouse mammary carcinoma. J Cancer Res Clin Oncol 119: 273-278.
15. Motulsky HJ, Stannard P, Neubig R, Platt M, Pilkington J (1994-1995): GraphPad Software: San Diego.
16. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M (1994) MIB1 Staining index and scoring of histologic features in meningioma. Cancer 74: 3176-3189.
17. Scambia G, Panici PB, Baiocchi G, Perrone L, Gaggini C, Iacobelli S, Mancuso S (1988): Growth inhibitory effect of LHRH analogs on human breast cancer cells. Anticancer Res 8: 187-190.
18. Schally AV (1989): The use of LH-RH analogs in gynaecology and tumor therapy. In: P Belfort, JA Pinotti, TKAB Eskes, (eds.), Advances in Gynaecology and Obstetrics: General Gynaecology. Carnforth: Parthenon Publishing, pp. 3-20.
19. Smith DA, Cahill DW (1994): The biology of the meningiomas. Neurosurg Clin N Am 5: 201-215.
20. Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV (1990): Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Endocrinology 127: 3052-3060.
21. Sutherland GR, Florell R, Louw D, Chio NW, Sima AAF (1987): Epidemiology of primary intracranial neoplasms in Manitoba, Canada. Can J Neurol Sci 14: 586-592.
22. Todo T, Adams EF, Fahlbusch R (1993): Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation. J Neurosurg 78: 463-469.
23. Unterman TG, Glick RP, Waites GT, Bell SC (1991): Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res 51: 3030-3036.
24. van Seters AP, van Dulken H, de Keizer RJW, Vielvoye GJ (1989): Symptomatic relief of meningioma by buserelin maintenance therapy. Lancet 11: 564-565.
25. Weisman AS, Villemure JG, Kelly PA (1986): Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Can Res 46: 2545-2551.
26. Yano T, Pinski J, Szepeshazi K, Szepeshazi K, Halmos G, Radulovic S, Groot K, Schally AV (1994): Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice. Cancer 15: 1229-1238.